on the last call i kept hearing dan p. stressing that they tried to operate in a measured and risk averse way and that they designed their molecules the same way. sorry i can't rememeber the phrase he used several times maybe i can get an assist. can you explain what dan p was saying as for how their drugs are designed to limit risk?
oh and i am still buying as well... use this time to keep nibbling shares...
Let me take a shot as a long time holder and rare poster with science/medical back ground. In the context you are speaking about I think he was stating that they have taken chemical structures of known anti-cancer efficacy and then combined them in a unique way. Another words the shape of the active moiety's are known for these compounds. They duplicated the active aspect of the molecules, but use there own unique chemistry and combined more than 1 active site into 1 molecule. This is well explained in there corporate slides. So de-risked as they are using approaches known to be effective. I believe the prior Scientist who has gone back to China thought of this and this is why they have kept a good relationship. Also why the compounds were initially synthesized in China.
thank you kindly. much appreciated. he seemed to really stress that more than usual this last call. i was starting to wonder if maybe he was trying to somehow differentiate say INFIs HH compound? i am in the software field so this cold fusion mumbo jumbo (biology) leaves me a lil dumbfounded sometimes.